Crossmark

Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases

Crossref DOI link: https://doi.org/10.1038/s41398-024-03222-1

Published Online: 2025-01-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pang, Jiao https://orcid.org/0009-0005-8721-2499
Cen, Changqian https://orcid.org/0009-0000-8444-0270
Tian, Yuan https://orcid.org/0009-0000-3070-8147
Cao, Xingrui https://orcid.org/0000-0003-2418-9920
Hao, Liang https://orcid.org/0009-0006-3569-4008
Tao, Xueshu https://orcid.org/0000-0001-9667-9617
Cao, Zhipeng https://orcid.org/0000-0002-4275-0788
License Information

Text and Data Mining valid from 2025-01-10

Version of Record valid from 2025-01-10
More Information

Article History

Received: 18 September 2024

Revised: 12 December 2024

Accepted: 31 December 2024

First Online: 10 January 2025

Competing interests

: The authors declare no competing interests.